Leonard L. Mazur's most recent trade in Citius Oncology Inc. was a trade of 800,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 12, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Citius Oncology Inc. | Leonard L. Mazur | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 800,000 | 800,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 600,000 | 600,000 | - | - | Stock Option (Right to Purchase Common Stock) | |
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 3,137,255 | 3,137,255 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2024 | 3,137,255 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 2,234,700 | 2,234,700 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2024 | 2,234,700 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Oncology Inc. | Leonard L. Mazur | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 3,700,000 | 3,700,000 | - | - | Stock Option (Right to Buy) | |
| Citius Oncology Inc. | Leonard L. Mazur | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 1,233,333 | 1,233,333 | - | - | Stock Option (Right to Buy) | |
| Tharimmune Inc | Leonard L. Mazur | Director | 09 Aug 2024 | 2,353 | 27,353 | - | - | Options (right to buy) | ||
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Apr 2024 | 1,165,048 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2024 | 1,165,048 | 1,165,048 | - | - | Warrant to Purchase Common Stock | |
| Hillstream BioPharma Inc | Leonard L. Mazur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 50,000 | 50,000 | - | - | Options (right to buy) | |
| Hillstream BioPharma Inc | Leonard L. Mazur | Director | 14 Jan 2022 | 98,733 | 98,733 | - | 3.2 | 315,946 | Common Stock | |
| Hillstream BioPharma Inc | Leonard L. Mazur | Director | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 14 Jan 2022 | 25,000 | 123,733 | - | 4 | 100,000 | Common Stock |
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2021 | 650,000 | 650,000 | - | - | Option to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 300,000 | 300,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Leonard L. Mazur | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2020 | 200,000 | 200,000 | - | - | Options to Purchase Common Stock |